Skip to main content
  • Tokai Pharmaceuticals, Inc. Rings The Nasdaq Stock Market Opening Bell

    Tokai went public in September 2014. The company’s lead drug candidate, galeterone, is a highly selective, multi-targeted, oral small molecule drug candidate for the treatment of prostate cancer.

    Learn more
  • BBJ: West Africa Ebola Outbreak Speeds Up Profectus BioSciences' Research

    Nearly $50 million in federal grants has helped advance its research and development of an Ebola vaccine.

    Learn More
  • University of Maryland, Baltimore Invests $100,000 to Complete Harpoon Medical's $3.6M Series A Financing

    U.S. Patent & Trademark Office (PTO) Issues Patent for Harpoon’s Minimally Invasive Mitral Valve Repair Device 

    Learn More
  • The Sky is the Limit with New Cloud Storage Solutions

    Data storage is one of the most popular applications of cloud computing.

    Learn More
  • Hot Technologies Available for Licensing

    UM Ventures is organized to move research outcomes into products and services, tools and diagnostics that will benefit society.

    Learn More

Receive Tech Alerts

Sign up to receive current new technology announcements and other UM Ventures news.

Select Your Interest(s)
University of Maryland, College Park
University of Maryland, Baltimore

UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.

Learn More